Method of inhibiting angiogenesis by using ephrin B2

It is intended to provide a method of inhibiting angiogenesis or neoangiogenesis and a composition therefor, and a method which is useful in treating a disease or a disorder relating to angiogenesis or neoangiogenesis and a composition therefor. The above-described compositions contain an effective...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FUJISAWA KIMIHIKO, KAGIMOTO TADAHISA, SASA YUKIO, ISHIBASHI TATSURO
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	It is intended to provide a method of inhibiting angiogenesis or neoangiogenesis and a composition therefor, and a method which is useful in treating a disease or a disorder relating to angiogenesis or neoangiogenesis and a composition therefor. The above-described compositions contain an effective amount of Ephrin B2 and the above-described methods involve the step of administering an effective amount of Ephrin B2. These compositions and methods are useful in treating a disease or a disorder relating to angiogenesis or neoangiogenesis. Moreover, these compositions and methods can inhibit neoangiogenesis from the retina.